Does MACITENTAN Cause Interstitial lung disease? 264 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 264 reports of Interstitial lung disease have been filed in association with MACITENTAN (OPSYNVI). This represents 0.6% of all adverse event reports for MACITENTAN.
264
Reports of Interstitial lung disease with MACITENTAN
0.6%
of all MACITENTAN reports
132
Deaths
171
Hospitalizations
How Dangerous Is Interstitial lung disease From MACITENTAN?
Of the 264 reports, 132 (50.0%) resulted in death, 171 (64.8%) required hospitalization, and 18 (6.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 264 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which MACITENTAN Alternatives Have Lower Interstitial lung disease Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE